Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Kadimastem Ltd
No Price
01.05.2026 20:00
Current Prices from Kadimastem Ltd
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
NCEL
USD
01.05.2026 20:00
3,85 USD
-0,56 USD
-12,70 %
IEX
NCEL
USD
01.05.2026 19:59
3,80 USD
-0,61 USD
-13,83 %
Share Float & Liquidity
Free Float20,20 %
Shares Float909.107,00
Shares Outstanding4,5 M
Company Profile for Kadimastem Ltd Share
Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; and IsletRx, a clinical grade pancreatic islet cell therapy treatment for diabetes. The company was incorporated in 2008 and is based in Ness Ziona, Israel.
